5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications

Acta Pharmaceutica Sinica B

Volumn 6, Issue 1, 2016, Pages 20-25

  Yao, Fan ^a   Zhang, Ming ^a   Chen, Li ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

AMP activated protein kinases; Autophagy; Diabetes; Diabetic complications

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

AUTOPHAGY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME MECHANISM; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLYCOGENOLYSIS; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; LIPOGENESIS; LIPOLYSIS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW;

EID: 84971554164     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2015.07.009     Document Type: Review

References (52)

1. Mackenzie RW, Elliott BT. Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes 2014, 7:55-64.
2. Ouyang CH, You JY, Xie ZL. The interplay between autophagy and apoptosis in the diabetic heart. J Mol Cell Cardiol 2014, 71:71-80.
3. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev 2009, 89:1025-1078.
4. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al. Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472:230-233.
5. Krishan S, Richardson DR, Sahni S. Adenosine monophosphate-activated kinase and its key role in catabolism: structure, regulation, biological activity, and pharmacological activation. Mol Pharmacol 2015, 87:363-377.
6. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007, 8:774-785.
7. Habegger KM, Hoffman NJ, Ridenour CM, Brozinick JT, Elmendorf JS. AMPK enhances insulin-stimulated GLUT4 regulation via lowering membrane cholesterol. Endocrinology 2012, 153:2130-2141.
8. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 2011, 331:456-461.
9. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13:132-141.
10. Liu XL, Niu YM, Yuan HR, Huang J, Fu L. AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. Metabolism 2015, 64:658-665.
11. Goginashvili A, Zhang ZR, Erbs E, Spiegelhalter C, Kessler P, Mihlan M, et al. Insulin secretory granules control autophagy in pancreatic β cells. Science 2015, 347:878-882.
12. Moruno F, Pérez-Jiménez E, Knecht E. Regulation of autophagy by glucose in mammalian cells. Cells 2012, 1:372-395.
13. Ravikumar B, Stewart A, Kita H, Kato K, Duden R, Rubinsztein DC. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum Mol Genet 2003, 12:985-994.
14. Kubli DA, Gustafsson A.B. Cardiomyocyte health: adapting to metabolic changes through autophagy. Trends Endocrinol Metab 2014, 25:156-164.
15. Choi KS. Autophagy and cancer. Exp Mol Med 2012, 44:109-120.
16. Kim J, Kim YC, Fang C, Russell RC, Kim JH, Fan WL, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 2013, 152:290-303.
17. Zou MH, Xie ZL. Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK. Autophagy 2013, 9:624-625.
18. Wang DK, Tian M, Qi Y, Chen G, Xu LJ, Zou X, et al. Jinlida granule inhibits palmitic acid induced-intracellular lipid accumulation and enhances autophagy in NIT-1 pancreatic β cells through AMPK activation. J Ethnopharmacol 2015, 161:99-107.
19. Dong HQ, Czaja MJ. Regulation of lipid droplets by autophagy. Trends Endocrinol Metab 2011, 22:234-240.
20. Singh R, Kaushik S, Wang YJ, Xiang YQ, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
21. Bachar-Wikstrom E, Wikstrom JD, Ariav Y, Tirosh B, Kaiser N, Cerasi E, et al. Stimulation of autophagy improves endoplasmic reticulum stress-induced diabetes. Diabetes 2013, 62:1227-1237.
22. Jiang YL, Huang W, Wang J, Xu ZP, He JY, Lin XH, et al. Metformin plays a dual role in MIN6 pancreatic β cell function through AMPK-dependent autophagy. Int J Biol Sci 2014, 10:268-277.
23. Chen ZF, Li YB, Han JY, Wang J, Yin JJ, Li JB, et al. The double-edged effect of autophagy in pancreatic β cells and diabetes. Autophagy 2011, 7:12-16.
24. Steinberg GR, Jorgensen SB. The AMP-activated protein kinase: role in regulation of skeletal muscle metabolism and insulin sensitivity. Mini Rev Med Chem 2007, 7:521-528.
25. Marsh BJ, Soden C, Alarcón C, Wicksteed BL, Yaekura K, Costin AJ, et al. Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine β-cells. Mol Endocrinol 2007, 21:2255-2269.
26. Fujimoto K, Hanson PT, Tran H, Ford EL, Han ZQ, Johnson JD, et al. Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation. J Biol Chem 2009, 284:27664-27673.
27. Dagon Y, Mantzoros C, Kim YB. Exercising insulin sensitivity: AMPK turns on autophagy!. Metabolism 2015, 64:655-657.
28. Sanchez AM, Csibi A, Raibon A, Cornille K, Gay S, Bernardi H, et al. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1. J Cell Biochem 2012, 113:695-710.
29. Shi LY, Zhang T, Liang XY, Hu Q, Huang J, Zhou Y, et al. Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway. Mol Cell Endocrinol 2015, 409:92-102.
30. Combs TP, Marliss EB. Adiponectin signaling in the liver. Rev Endocr Metab Disord 2014, 15:137-147.
31. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100:328-341.
32. Deepa SS, Dong LQ. APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab 2009, 296:E22-E36.
33. Deepa SS, Zhou LJ, Ryu J, Wang CH, Mao XM, Li C, et al. APPL1 mediates adiponectin-induced LKB1 cytosolic localization through the PP2A-PKCζ signaling pathway. Mol Endocrinol 2011, 25:1773-1785.
34. Wang CH, Xin XB, Xiang RH, Ramos FJ, Liu ML, Lee HJ, et al. Yin-yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem 2009, 284:31608-31615.
35. Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-κB activation in vascular endothelial cells. FEBS Lett 2008, 582:1719-1724.
36. 2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 2009, 284:22426-22435.
37. 2+ and AMPK/SIRT1. Nature 2010, 464:1313-1319.
38. Forbes JM. The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the key. Am J Pathol 2010, 177:1600-1602.
39. Zhao MT, Klionsky DJ. AMPK-dependent phosphorylation of ULK1 induces autophagy. Cell Metab 2011, 13:119-120.
40. Cowerd RB, Asmar MM, Alderman JM, Alderman EA, Garland AL, Busby WH, et al. Adiponectin lowers glucose production by increasing SOGA. Am J Pathol 2010, 177:1936-1945.
41. Camacho RC, Pencek RR, Lacy DB, James FD, Donahue EP, Wasserman DH. Portal venous 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output. Diabetes 2005, 54:373-382.
42. Kundu S, Pushpakumar S, Khundmiri SJ, Sen U. Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activated protein kinase signaling. Biochim Biophys Acta 2014, 1843:2816-2826.
43. Puri P, Chandra A. Autophagy modulation as a potential therapeutic target for liver diseases. J Clin Exp Hepatol 2014, 4:51-59.
44. Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F, et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 2011, 123:1073-1082.
45. Zhang DH, Contu R, Latronico MV, Zhang JL, Rizzi R, Catalucci D, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Investig 2010, 120:2805-2816.
46. Mellor KM, Bell JR, Young MJ, Ritchie RH Delbridge LMD. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol 2011, 50:1035-1043.
47. Levine B, Yuan JY. Autophagy in cell death: an innocent convict?. J Clin Investig 2005, 115:2679-2688.
48. Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol 2015, 224:R15-R30.
49. Fang L, Zhou Y, Cao HD, Wen P, Jiang L, He WC, et al. Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia-induced podocyte injury. PLoS One 2013, 8:e60546.
50. Cinà DP, Onay T, Paltoo A, Li CJ, Maezawa Y, De Arteaga J, et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 2012, 23:412-420.
51. Yamahara K, Kume S, Koya D, Tanaka Y, Morita Y, Chin-Kanasaki M, et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 2013, 24:1769-1781.
52. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.